$ROIV

$36.54 +$0.49 (1.36%) Close

$ROIV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ROIV Management Team

Ms. Jennifer Humes

Chief Accounting Officer

Age 44

Compensation $2.383M USD

Sex Female

Dr. Frank Torti

President and Vant Chairman

Age 46

Compensation -

Sex Male

Mr. Ilan Oren

Independent Chairman of the Board

Age 41

Compensation $521.5K USD

Sex Male

Dr. Mayukh Sukhatme

President

Chief Investment Officer

Director

Age 49

Compensation $251.9M USD

Sex Male

Mr. Matthew Gline

Chief Executive Officer

Director

Age 41

Compensation $163.3M USD

Sex Male

Mr. Richard Pulik

Chief Financial Officer

Age 46

Compensation $4.127M USD

Sex Male

Dr. Eric Venker

President and Immunovant Chief Executive Officer

Age 38

Compensation $11.81M USD

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Jennifer Humes Chief Accounting Officer	44	$2.383M USD	Female
Dr. Frank Torti President and Vant Chairman	46	-	Male
Mr. Ilan Oren Independent Chairman of the Board	41	$521.5K USD	Male
Dr. Mayukh Sukhatme President Chief Investment Officer Director	49	$251.9M USD	Male
Mr. Matthew Gline Chief Executive Officer Director	41	$163.3M USD	Male
Mr. Richard Pulik Chief Financial Officer	46	$4.127M USD	Male
Dr. Eric Venker President and Immunovant Chief Executive Officer	38	$11.81M USD	Male

Board of Directors

From the proxy statement filed Jul 29, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy

Average tenure

Not stated

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	Pay
Oren	Not stated	Not stated	Independent	None stated	None stated	Not stated
FitzGerald	Not stated	Not stated	Independent	None stated	None stated	Not stated
Epperly	Not stated	Not stated	Independent	None stated	None stated	Not stated
Manchester	Not stated	Not stated	Independent	None stated	None stated	Not stated
Gold	Not stated	Not stated	Independent	None stated	None stated	Not stated
Momtazee	Not stated	Not stated	Independent	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Jul 29, 2026

Brett Venker

brother of Eric Venker, Roivant's President and Immunovant CEO

Amount not stated

Fiscal 2025

Employment of Brett Venker as Vice President of Operations for subsidiary Covant, with cash compensation and equity incentive awards

With Covant Open in proxy

Comments

Company Executives

$ROIV Management Team

Ms. Jennifer Humes

Dr. Frank Torti

Mr. Ilan Oren

Dr. Mayukh Sukhatme

Mr. Matthew Gline

Mr. Richard Pulik

Dr. Eric Venker

Board of Directors

Related-party transactions